细胞死亡信号中的棕化代码:从分子机制到治疗机会
Han-Xi Xiao1,2, Zhou-Zhou Li1,2, Xu-Huan Li3
1Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Frontiers in cell and developmental biology
|March 12, 2026
概括
蛋白棕化调节细胞死亡途径,对细胞存活至关重要. 这种脂质修饰改变了脂质.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 蛋白质棕化是一种动态的脂质修饰,调节蛋白质的功能和局部化.
- 它在细胞生存和死亡途径中起着至关重要的作用.
- 失调与各种人类疾病有关.
研究的目的:
- 探索不同细胞死亡途径中的棕化分子调节.
- 了解它在疾病发病过程中的作用.
- 为了确定与棕化相关的治疗点.
主要方法:
- 文献综述和对棕细胞代谢现有研究的分析.
- palmitoylation 在亡,铁亡,热亡和亡中的作用的检查.
- 研究其在癌症,神经退行性和炎症性疾病中的参与.
主要成果:
- 棕化通过调节蛋白质稳定性,膜定和相互作用来精确控制细胞命运.
- 它在瘤进展中具有双重作用,可能促进或抑制瘤进展.
- 它对于炎症信号发送在热和细胞防御铁中至关重要.
结论:
- 了解棕细胞的调节网络提供了有前途的治疗点.
- 向棕化酶是新型疾病治疗的创新策略.
- 这种方法显示出显著的临床翻译潜力.
相关概念视频
Overview of Cell Death
10.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.8K
The Intrinsic Apoptotic Pathway
9.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
The Extrinsic Apoptotic Pathway
9.2K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
Autophagic Cell Death
4.9K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.9K
Apoptosis
16.6K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.6K
PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K


